allogeneic

Type: Keyphrase
Name: allogeneic
First reported Aug 25 2014 - Updated Aug 25 2014 - 1 reports

Stemedica International Posts Alzheimer’s Stem Cell Data

Stemedica International S.A., a Stemedica Cell Technologies Inc. subsidiary developing stem cell therapies for Alzheimer’s disease and dementia, revealed the first results of an intravenous administration of allogeneic, human, ischemia-tolerant mesenchymal ... [Published Drug Discovery and Development - Aug 25 2014]
First reported Aug 20 2014 - Updated Aug 20 2014 - 1 reports

Researchers from Medical University Describe Findings in Stem Cells (Clofarabine/cyclophosphamide for debulking before stem cell transplantation)

By a News Reporter-Staff News Editor at Biotech Week -- Investigators publish new report on Stem Cell Research. According to news reporting from Vienna, Austria, by NewsRx journalists, research stated, "Allogeneic haematopoietic stem cell transplantation ... [Published Street Sweeper - Aug 20 2014]
First reported Aug 20 2014 - Updated Aug 20 2014 - 1 reports

Stemedica International Announces Pre-clinical Data Of Its Alzheimer???s Study

EPALINGES, Switzerland--(BUSINESS WIRE)--Stemedica International S.A., a Stemedica Cell Technologies Inc. subsidiary developing stem cell therapies for Alzheimer’s disease and dementia, revealed the first results of an intravenous administration of allogeneic, ... [Published BioSpace - Aug 20 2014]
First reported Aug 20 2014 - Updated Aug 20 2014 - 1 reports

Terumo to Evaluate Clinical Cell Production Using Quantum System

Terumo BCT's  Quantum Cell Expansion System  is now under evaluation by Athersys, Inc., a biopharmaceutical company dedicated to the research and development of stem cell therapies, as a manufacturing platform for Athersys' allogeneic multipotent adult ... [Published PharmaAsia - Aug 20 2014]
First reported Aug 20 2014 - Updated Aug 20 2014 - 1 reports

Chemically extracted acellular allogeneic nerve graft with CNTF for sciatic nerve repair

PUBLIC RELEASE DATE: 20-Aug-2014Chemically extracted acellular allogeneic nerve, from which Schwann cells, myelin sheath and disintegrating fragments have been removed, reduced postoperative immune rejection. Simultaneously, chemically extracted acellular ... [Published EurekAlert! - Aug 20 2014]
First reported Aug 18 2014 - Updated Aug 18 2014 - 1 reports

MiR-152 May Silence Translation of CaMK II and Induce Spontaneous Immune Tolerance in Mouse Liver Transplantation

by Yan Wang, Yang Tian, Yuan Ding, Jingcheng Wang, Sheng Yan, Lin Zhou, Haiyang Xie, Hui Chen, Hui Li, Jinhua Zhang, Jiacong Zhao, Shusen ZhengSpontaneous immune tolerance in mouse liver transplantation has always been a hotspot in transplantation-immune ... [Published Plosone.org - Aug 18 2014]
First reported Aug 18 2014 - Updated Aug 18 2014 - 1 reports

Stem Cell Technologies Market by Treatment Mode (Autologous & Allogeneic) & Therapeutic Applications 2020

The global stem cell therapy market is expected to reach $330 million by 2020, at a CAGR of 39.5% from 2015 to 2020.A number of factors such as increasing funding from government and private organizations, growing industry focus on stem cell research, ... [Published Individual.com - Aug 18 2014]
First reported Aug 16 2014 - Updated Aug 16 2014 - 1 reports

Bone cell therapy in first clinical trial

The allogeneic osteoblastic cell therapy product, Allob, made by Bone Therapeutics SA – a regenerative therapy co mpany based in Belgium – has been used to treat a patient for the first time. ... [Published Performance Materials Net - Aug 16 2014]
First reported Aug 13 2014 - Updated Aug 13 2014 - 1 reports

Phase 2a heart failure trial begins

SAN DIEGO—CardioCell LLC, a subsidiary, has begun a Phase 2a clinical trial for chronic heart failure, the first launch in the company’s heart failure (HF) program. The study will seek to evaluate the safety, tolerability and preliminary efficacy of an ... [Published Drug Discovery News - Aug 13 2014]
First reported Aug 11 2014 - Updated Aug 11 2014 - 2 reports

テルモBCTがQuantumシステムによる臨床用細胞生産を評価するための提携を発表

米コロラド州レイクウッド--(BUSINESS WIRE)--Terumo BCT’s Quantum® Cell Expansion System is under evaluation by Athersys, Inc.,as a manufacturing platform for allogeneic multipotent adult progenitor cell products. ... [Published Business Wire Science: Science News - Aug 11 2014]
First reported Aug 07 2014 - Updated Aug 08 2014 - 4 reports

Terumo BCT Announces Collaboration to Evaluate Clinical Cell Production Using Quantum System

Project to evaluate system’s capability and scalability in manufacturing allogeneic cell therapies for clinical useLAKEWOOD, Colo.--(BUSINESS WIRE)-- Terumo BCT’s Quantum ® Cell Expansion System is now under evaluation by Athersys, Inc., a biopharmaceutical ... [Published CNBC - Aug 07 2014]
First reported Aug 05 2014 - Updated Aug 05 2014 - 1 reports

Impact of Cotransplantation of Mesenchymal Stem Cells on Lung Function After Unrelated Allogeneic Hematopoietic Stem Cell Transplantation Following Non-Myeloablative Conditioning

BackgroundIn the context of hematopoietic stem cell transplantation (HSCT), mesenchymal stem cells (MSC) have been used to promote engraftment and prevent graft-versus-host disease. However, in animal models, MSC were shown to cause pulmonary alterations ... [Published Transplantation - Aug 05 2014]

Quotes

...Regeneus Commercial Development Director for Human Health , Steve Barbera , said, "It's pleasing that HiQCell has been approved under the new AFL Prohibited Treatments List released in March 2014 . HiQCell also received clearance as an approved therapy from the Australian Sports Anti-Doping Authority (ASADA) for use with athletes who participate in sporting competitions subject to the WADA Anti-Doping Code, including the AFL. This recent decision by the AFL demonstrates a further level of compliance, specifically for players within that sporting code"
...that, will lay our final plans for associated marketing initiatives and strategies," said William Tew, Ph D , BioTime's Chief Commercial Officer. "HyStem-based products such as Premvia? and Renevia? (the latter anticipated to begin its pivotal clinical trial in Europe later this year) are anticipated to provide the company with opportunities for significant near-term revenue, while balancing the long-term opportunities created by the Company's pluripotent stem cell technology platform, which provides the potential for the industrial-scale manufacture of all of the cellular components of the human body. Together, these matrices and cellular building blocks provide a combination of technology platforms that we believe can lead the industry in the revolution underway commonly called 'regenerative medicine.'"
Regeneus CEO professor Graham Vesey said: "This agreement allows Regeneus to cost effectively fast-track the production of Regeneus' off-the shelf Progenza product for preclinical and clinical trials for market entry into Japan."

More Content

All (288) | News (212) | Reports (0) | Blogs (64) | Audio/Video (0) | Fact Sheets (0) | Press Releases (5)
sort by: Date | Relevance
REGENEUS : AFL approves use of Regeneus Ltd's (... [Published 4 Traders - 17 hours ago]
StemCutis Attracts Stem Cell Entrepreneur As Pr... [Published BioSpace - 22 hours ago]
StemCutis Attracts Stem Cell Entrepreneur Dr. I... [Published Fort Mills Times - Aug 26 2014]
StemCutis Attracts Stem Cell Entrepreneur Dr. I... [Published CW Atlanta - Aug 26 2014]
OMBP: Omni Bio Executing On Development Plan [Published Yahoo! Finance - Aug 26 2014]
TiGenix Business and Financial Update for the -3- [Published Scottrade - Aug 26 2014]
TiGenix Business and Financial Update for the F... [Published GlobeNewswire: Acquisitions News - Aug 26 2014]
Mesoblast Unveils Path to Bring Its Key Product... [Published Franklin Credit Management Corporation - Aug 26 2014]
Involvement of Toll-Like Receptors on Helicobac... [Published Plosone.org - Aug 25 2014]
Reconstruction of Beagle Hemi-Mandibular Defect... [Published Plosone.org - Aug 25 2014]
Stemedica International Posts Alzheimer’s Stem ... [Published Drug Discovery and Development - Aug 25 2014]
Asterias Biotherapeutics Announces Investor Bri... [Published Bio-Medicine - Aug 25 2014]
8/25/14 - BioTime Receives FDA Premarket Notifi... [Published Pharmacy Choice - Aug 25 2014]
OpportunityAnalyzer: Graft-Versus-Host Disease ... [Published Global Information Inc - Aug 25 2014]
Haplo-identical Bone Marrow Transplantation [Published Prlog - Aug 25 2014]
Pharmaceutical Executive Joins Mesoblast As Chi... [Published Good Day Sacramento - Aug 25 2014]
GVHD Market (Graft-Versus-Host Disease) Growing... [Published EMAILWIRE.com - Aug 22 2014]
Regeneus, Cryosite to jointly manufacture human... [Published Pharmaceutical Business Review - Aug 21 2014]
Asterias Biotherapeutics Appoints Two Independe... [Published Wall Street Select - Aug 21 2014]
Regeneus in stem cell manufacturing partnership... [Published Proactiveinvestors United Kingdom website - Aug 21 2014]
T-Cell Immunotherapy for Cytomegalovirus [Published UCL Biomedica - Aug 21 2014]
Regeneus forms stem cell manufacturing partners... [Published Proactive Investors Australia - Aug 21 2014]
Patent Issued for Rhodamine Derivatives for Pho... [Published HispanicBusiness.com - Aug 21 2014]
Patent Application Titled "Cartilage Material" ... [Published HispanicBusiness.com - Aug 21 2014]
Researchers from Medical University Describe Fi... [Published Street Sweeper - Aug 20 2014]
Novartis Signs Investment And Option Agreement ... [Published Bioresearch Online - Aug 20 2014]
Bone Marrow Drive, Sept. 20th @ Guilderland YMCA [Published Times Union - Aug 20 2014]
What 'Chasing Life,' On ABC Family, Gets Right ... [Published Forbes.com - Aug 20 2014]
Stemedica International Announces Pre-clinical ... [Published BioSpace - Aug 20 2014]
Terumo to Evaluate Clinical Cell Production Usi... [Published PharmaAsia - Aug 20 2014]
1 2 3 4 5 6 7 8 9 10
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Regeneus in stem cell manufacturing partnership... [Published Proactiveinvestors United Kingdom website - Aug 21 2014]
Regenerative medicine company Regeneus ( ASX:RGS ) has signed an agreement with Cryosite ( ASX:CTE ) to collaborate on the development and manufacture of new stem cell products for human applications.This includes fast-tracking production of its off-the ...
Researchers Identify Tests to Diagnose Invasive... [Published theCSRfeed - Aug 14 2014]
Early, more accurate detection of this potentially deadly fungus can improve patient outcomes, according to new report in The Journal of Molecular Diagnostics SOURCE: Elsevier DESCRIPTION: Philadelphia, PA, August 14, 2014 /3BL Media/ – The fungal ...
Advanced Biologics publishes additional OsteoAM... [Published PR Newswire: General Business - Aug 13 2014]
CARLSBAD, Calif., Aug. 13, 2014 /PRNewswire/ -- Advanced Biologics announced today the acceptance for publication of a new OsteoAMP study to be published in the Journal of Spine.  In the study titled, Clinical Validation of Allogeneic Morphogenetic Protein: ...
テルモBCTがQuantumシステムによる臨床用細胞生産を評価するための提携を発表 [Published Business Wire Science: Science News - Aug 11 2014]
米コロラド州レイクウッド--(BUSINESS WIRE)--Terumo BCT’s Quantum® Cell Expansion System is under evaluation by Athersys, Inc.,as a manufacturing platform for allogeneic multipotent adult progenitor cell products. ...
テルモBCTがQuantumシステムによる臨床用細胞生産を評価するための提携を発表 [Published Business Wire Health News - Aug 11 2014]
米コロラド州レイクウッド--(BUSINESS WIRE)--Terumo BCT’s Quantum® Cell Expansion System is under evaluation by Athersys, Inc.,as a manufacturing platform for allogeneic multipotent adult progenitor cell products. ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
TiGenix Business and Financial Update for the F... [Published GlobeNewswire: Acquisitions News - Aug 26 2014]
Cesca Therapeutics and Fortis Healthcare Announ... [Published GlobeNewswire: Acquisitions News - Aug 05 2014]
TiGenix announces the clinical development of C... [Published GlobeNewswire: Advertising News - Jun 30 2014]
Immunicum’s abstract with data from a kidney ca... [Published GlobeNewswire: Acquisitions News - Mar 27 2014]
Immunicum reports promising preclinical results... [Published GlobeNewswire: Advertising News - Mar 06 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.